Published in JAMA on February 09, 2005
Development and validation of a predictive model for chemotherapy-associated thrombosis. Blood (2008) 4.06
Trousseau's syndrome: multiple definitions and multiple mechanisms. Blood (2007) 3.32
Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg (2012) 2.25
Assessing risk of venous thromboembolism in the patient with cancer. J Clin Oncol (2009) 2.22
Association between incident cancer and subsequent stroke. Ann Neurol (2015) 2.13
Epidemiology and pathophysiology of cancer-associated thrombosis. Br J Cancer (2010) 1.93
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
Blood transfusions, thrombosis, and mortality in hospitalized patients with cancer. Arch Intern Med (2008) 1.85
The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med (2007) 1.70
Leukocytosis, thrombosis and early mortality in cancer patients initiating chemotherapy. Thromb Res (2010) 1.66
Variation in thromboembolic complications among patients undergoing commonly performed cancer operations. J Vasc Surg (2012) 1.65
Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysis. PLoS Med (2012) 1.60
Risk factors for venous and arterial thrombosis. Blood Transfus (2010) 1.58
Tissue factor expressed by circulating cancer cell-derived microparticles drastically increases the incidence of deep vein thrombosis in mice. J Thromb Haemost (2015) 1.46
Clinical features from the history and physical examination that predict the presence or absence of pulmonary embolism in symptomatic emergency department patients: results of a prospective, multicenter study. Ann Emerg Med (2010) 1.37
The Prophylaxis of Venous Thromboembolism. Dtsch Arztebl Int (2016) 1.36
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med (2006) 1.27
Venous thromboembolic disease and cancer. Postgrad Med J (2006) 1.23
Meta-analysis of 65,734 individuals identifies TSPAN15 and SLC44A2 as two susceptibility loci for venous thromboembolism. Am J Hum Genet (2015) 1.23
Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood (2010) 1.17
Incidence of pulmonary embolism in oncologic outpatients at a tertiary cancer center. Cancer (2011) 1.15
Hospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006. Br J Cancer (2010) 1.14
Promotion of experimental thrombus formation by the procoagulant activity of breast cancer cells. Phys Biol (2011) 1.13
New insights into cancer-associated thrombosis. Arterioscler Thromb Vasc Biol (2009) 1.11
Epidemiology of cancer-related venous thromboembolism. Best Pract Res Clin Haematol (2009) 1.11
Health care costs associated with venous thromboembolism in selected high-risk ambulatory patients with solid tumors undergoing chemotherapy in the United States. Clinicoecon Outcomes Res (2013) 1.09
Efficacy and safety of high-dose thromboprophylaxis in morbidly obese inpatients. Thromb Haemost (2013) 1.08
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Pulmonary fibrosis is associated with an elevated risk of thromboembolic disease. Eur Respir J (2011) 1.07
Inferior vena cava filtration in the management of venous thromboembolism: filtering the data. Semin Intervent Radiol (2012) 1.07
Evidence for tissue factor phosphorylation and its correlation with protease-activated receptor expression and the prognosis of primary breast cancer. Int J Cancer (2010) 1.05
Tissue factor activity is increased in a combined platelet and microparticle sample from cancer patients. Thromb Res (2008) 1.04
Standard perioperative management in gastrointestinal surgery. Langenbecks Arch Surg (2011) 1.03
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med (2012) 1.03
Venous thromboembolism in patients with acute leukemia: incidence, risk factors, and effect on survival. Blood (2008) 1.03
Common genetic risk factors for venous thrombosis in the Chinese population. Am J Hum Genet (2013) 1.01
Proteasome inhibitors enhance endothelial thrombomodulin expression via induction of Krüppel-like transcription factors. Arterioscler Thromb Vasc Biol (2009) 0.99
Interleukin levels and their potential association with venous thromboembolism and survival in cancer patients. Clin Exp Immunol (2014) 0.98
Cancer-associated thrombosis: clinical presentation and survival. Cancer Manag Res (2013) 0.98
Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol (2010) 0.98
Incidence, risk factors and consequences of portal vein and systemic thromboses in hepatocellular carcinoma. Thromb Res (2007) 0.98
A follow-up study of a genome-wide association scan identifies a susceptibility locus for venous thrombosis on chromosome 6p24.1. Am J Hum Genet (2010) 0.98
Guidance for the treatment of deep vein thrombosis and pulmonary embolism. J Thromb Thrombolysis (2016) 0.96
Idiopathic superficial thrombophlebitis and the incidence of cancer in primary care patients. Ann Fam Med (2010) 0.95
Incidental pulmonary embolism in cancer patients: clinical characteristics and outcome--a comprehensive cancer center experience. Vasc Health Risk Manag (2011) 0.95
Natural health products that inhibit angiogenesis: a potential source for investigational new agents to treat cancer-Part 2. Curr Oncol (2006) 0.94
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94
Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94
Venous thromboembolic disease. J Natl Compr Canc Netw (2011) 0.93
Regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica (2013) 0.93
IVC filters may prevent fatal pulmonary embolism in musculoskeletal tumor surgery. Clin Orthop Relat Res (2008) 0.92
Modeling and simulation of procoagulant circulating tumor cells in flow. Front Oncol (2012) 0.92
Factor V-Leiden Mutation: A Common Risk Factor for Venous Thrombosis among Lebanese Patients. Thrombosis (2012) 0.91
A post hoc analysis of dalteparin versus oral anticoagulant (VKA) therapy for the prevention of recurrent venous thromboembolism (rVTE) in patients with cancer and renal impairment. J Thromb Thrombolysis (2016) 0.91
Thromboprophylaxis with low-molecular-weight heparin in medical patients with cancer. Cancer (2009) 0.90
Pathologies at the nexus of blood coagulation and inflammation: thrombin in hemostasis, cancer, and beyond. J Mol Med (Berl) (2013) 0.90
Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancer. Ann Oncol (2011) 0.89
Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study. J Transl Med (2011) 0.89
Cancer and venous thromboembolic disease: from molecular mechanisms to clinical management. Curr Oncol (2014) 0.88
Synergistic effects of hypofibrinolysis and genetic and acquired risk factors on the risk of a first venous thrombosis. PLoS Med (2008) 0.88
Thrombosis and cancer. Nat Rev Clin Oncol (2012) 0.88
Cancer-associated thrombosis, low-molecular-weight heparin, and the patient experience: a qualitative study. Patient Prefer Adherence (2014) 0.88
Inferior vena cava filters for primary prophylaxis: when are they indicated? Semin Intervent Radiol (2012) 0.88
Venous thromboembolism risk in patients with cancer receiving chemotherapy: a real-world analysis. Oncologist (2013) 0.87
An unusual presentation of metastatic adenocarcinoma of lung: a case report. Cases J (2009) 0.87
Prophylactic and therapeutic anticoagulation for thrombosis: major issues in oncology. Nat Clin Pract Oncol (2008) 0.87
Venous thromboembolism and cancer risk among elderly adults in the United States. Cancer Epidemiol Biomarkers Prev (2014) 0.86
Primary prevention of venous thromboembolism in medical and surgical oncology patients. Br J Cancer (2010) 0.86
High rates of symptomatic and incidental thromboembolic events in gastrointestinal cancer patients. J Thromb Haemost (2010) 0.86
Clinical Significance of Preoperative Thrombin Time in Patients with Esophageal Squamous Cell Carcinoma following Surgical Resection. PLoS One (2015) 0.85
Acute pulmonary embolism. Part 1: epidemiology and diagnosis. Nat Rev Cardiol (2010) 0.85
Inflammation, TNFα and endothelial dysfunction link lenalidomide to venous thrombosis in chronic lymphocytic leukemia. Am J Hematol (2011) 0.84
Pathogenesis and treatment of thrombohemorrhagic diathesis in acute promyelocytic leukemia. Mediterr J Hematol Infect Dis (2011) 0.84
Risk Factors of a Pulmonary Thromboembolism After Colorectal Surgery. Ann Coloproctol (2015) 0.84
Biomolecular markers of cancer-associated thromboembolism. Crit Rev Oncol Hematol (2013) 0.84
Prothrombotic state in senile patients with acute exacerbations of chronic obstructive pulmonary disease combined with respiratory failure. Exp Ther Med (2013) 0.83
Improving accuracy of International Classification of Diseases codes for venous thromboembolism in administrative data. Thromb Res (2015) 0.82
Colon cancer metastasis in mouse liver is not affected by hypercoagulability due to Factor V Leiden mutation. J Cell Mol Med (2007) 0.82
Haemostatic alterations in a group of canine cancer patients are associated with cancer type and disease progression. Acta Vet Scand (2012) 0.82
Finding the origin of pulmonary emboli with a total-body magnetic resonance direct thrombus imaging technique. Haematologica (2012) 0.82
CATCH: a randomised clinical trial comparing long-term tinzaparin versus warfarin for treatment of acute venous thromboembolism in cancer patients. BMC Cancer (2013) 0.82
Differential effects of anticoagulants on tumor development of mouse cancer cell lines B16, K1735 and CT26 in lung. Clin Exp Metastasis (2008) 0.82
Long-term use of daily subcutaneous low molecular weight heparin in cancer patients with venous thromboembolism: why hesitate any longer? Support Care Cancer (2008) 0.82
Pulmonary embolism due to internal jugular vein thrombosis in a patient with non-small cell lung cancer receiving bevacizumab. Int J Clin Oncol (2010) 0.82
Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice. J Thromb Haemost (2015) 0.81
Is thrombophilia a major risk factor for deep vein thrombosis of the lower extremities among Lebanese patients? Vasc Health Risk Manag (2009) 0.81
Patients' Experiences of LIving with CANcer-associated thrombosis: the PELICAN study. Patient Prefer Adherence (2015) 0.81
F9 Malmö, factor IX and deep vein thrombosis. Haematologica (2009) 0.81
Impact of comorbidity on risk of venous thromboembolism in patients with breast cancer: a Danish population-based cohort study. BMJ Open (2014) 0.81
Low C-reactive protein levels in a traditional West-African population living in a malaria endemic area. PLoS One (2013) 0.81
Impact of chemotherapy on venous thromboembolism: comment to: regional lymph node metastases are a strong risk factor for venous thromboembolism: results from the Vienna Cancer and Thrombosis Study. Haematologica (2013) 0.80
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf (2012) 0.80
Cancer and coagulation. Am J Hematol (2012) 0.80
Cancer-associated thrombosis. Open Cardiovasc Med J (2010) 0.80
The thrombotic potential of circulating tumor microemboli: computational modeling of circulating tumor cell-induced coagulation. Am J Physiol Cell Physiol (2014) 0.80
Occurrence of Deep Vein Thrombosis among Hospitalized Non-Surgical Japanese Patients. Ann Vasc Dis (2015) 0.80
Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet (2011) 13.25
Preoperative anaemia and postoperative outcomes in non-cardiac surgery: a retrospective cohort study. Lancet (2011) 4.27
A randomized trial of genotype-guided dosing of acenocoumarol and phenprocoumon. N Engl J Med (2013) 4.27
Association of genetic variations with nonfatal venous thrombosis in postmenopausal women. JAMA (2007) 3.50
Estrogen plus progestin and risk of venous thrombosis. JAMA (2004) 3.46
Patterns of care in the management of seminoma stage I: results from a European survey. BJU Int (2012) 3.41
Risk assessment for recurrent venous thrombosis. Lancet (2010) 3.31
Evaluation of short-term consequences of hypoglycemia in an intensive care unit. Crit Care Med (2006) 3.13
Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA (2005) 3.04
Prevention of venous thromboembolism after major orthopaedic surgery: is fondaparinux an advance? Lancet (2003) 2.98
Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA (2009) 2.85
Predisposing factors for hypoglycemia in the intensive care unit. Crit Care Med (2006) 2.75
Gene variants associated with deep vein thrombosis. JAMA (2008) 2.74
Osteoarthritis of the knee: association between clinical features and MR imaging findings. Radiology (2006) 2.62
Different combined oral contraceptives and the risk of venous thrombosis: systematic review and network meta-analysis. BMJ (2013) 2.45
Hypoglycemia is associated with intensive care unit mortality. Crit Care Med (2010) 2.41
Glucose-insulin-potassium infusion inpatients treated with primary angioplasty for acute myocardial infarction: the glucose-insulin-potassium study: a randomized trial. J Am Coll Cardiol (2003) 2.40
Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study: a case-control study. Lancet Neurol (2009) 2.37
Combined oral contraceptives: venous thrombosis. Cochrane Database Syst Rev (2014) 2.28
Etiology, management, and outcome of the Budd-Chiari syndrome. Ann Intern Med (2009) 2.26
Optimal level of oral anticoagulant therapy for the prevention of arterial thrombosis in patients with mechanical heart valve prostheses, atrial fibrillation, or myocardial infarction: a prospective study of 4202 patients. Arch Intern Med (2009) 2.16
Turbid plasma donations in whole blood donors: fat chance? Transfusion (2011) 2.15
Risks of oral anticoagulant therapy with increasing age. Arch Intern Med (2005) 2.06
Lowering the intensity of oral anticoagulant therapy: effects on the risk of hemorrhage and thromboembolism. Arch Intern Med (2004) 2.00
Is an EMA review on hormonal contraception and thrombosis needed? BMJ (2013) 1.94
Smoking increases the risk of venous thrombosis and acts synergistically with oral contraceptive use. Am J Hematol (2008) 1.93
Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost (2003) 1.80
Pre-analytical and analytical issues in the analysis of blood microparticles. Thromb Haemost (2010) 1.80
High VWF, low ADAMTS13, and oral contraceptives increase the risk of ischemic stroke and myocardial infarction in young women. Blood (2011) 1.78
Incidence and risk factors of early venous thrombosis associated with permanent pacemaker leads. J Cardiovasc Electrophysiol (2004) 1.72
Multiple SNP testing improves risk prediction of first venous thrombosis. Blood (2012) 1.70
Esterified estrogens and conjugated equine estrogens and the risk of venous thrombosis. JAMA (2004) 1.70
Serum lipid levels and the risk of venous thrombosis. Arterioscler Thromb Vasc Biol (2004) 1.69
The relationship between tissue factor and cancer progression: insights from bench and bedside. Blood (2011) 1.61
Risk of venous thrombosis: obesity and its joint effect with oral contraceptive use and prothrombotic mutations. Br J Haematol (2007) 1.61
Smoking and the risk of mortality and vascular and respiratory events in patients undergoing major surgery. JAMA Surg (2013) 1.57
Determinants of survival and the effect of portosystemic shunting in patients with Budd-Chiari syndrome. Hepatology (2004) 1.57
Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol (2010) 1.55
Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: Opposite and synergistic effects of factors XI and XII. Blood (2006) 1.52
The effect of flight-related behaviour on the risk of venous thrombosis after air travel. Br J Haematol (2008) 1.50
Venous thrombosis and conjugated equine estrogen in women without a uterus. Arch Intern Med (2006) 1.50
Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol (2012) 1.50
Prevention of coagulase-negative staphylococcal central venous catheter-related infection using urokinase rinses: a randomized double-blind controlled trial in patients with hematologic malignancies. J Clin Oncol (2008) 1.49
The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood (2013) 1.47
Mutations in clotting factors and inflammatory bowel disease. Am J Gastroenterol (2006) 1.47
Genetic variation in the fibrinogen gamma gene increases the risk for deep venous thrombosis by reducing plasma fibrinogen gamma' levels. Blood (2005) 1.46
Subtherapeutic oral anticoagulant therapy: frequency and risk factors. Thromb Haemost (2009) 1.46
Management of adverse events associated with the use of everolimus in patients with advanced renal cell carcinoma. Eur J Cancer (2011) 1.45
Bleeding in carriers of hemophilia. Blood (2006) 1.41
Factor V Leiden, prothrombin G20210A, and risk of sudden coronary death in apparently healthy persons. Am J Cardiol (2002) 1.41
Clinical outcome of patients with implantation of second-generation drug-eluting stents in the right coronary ostium: insights from 2-year follow-up of the TWENTE trial. Catheter Cardiovasc Interv (2014) 1.40
Prothrombotic gene variation in patients with large and small vessel disease. Neuroepidemiology (2008) 1.40
Fluid loss does not explain coagulation activation during air travel. Thromb Haemost (2008) 1.38
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells. J Clin Oncol (2005) 1.30
The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer. Clin Cancer Res (2010) 1.28
Travel-related venous thrombosis: results from a large population-based case control study (MEGA study). PLoS Med (2006) 1.27
Genotype-guided dosing of coumarin derivatives: the European pharmacogenetics of anticoagulant therapy (EU-PACT) trial design. Pharmacogenomics (2009) 1.25
Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. JAMA (2002) 1.23
Interleukin 8 and venous thrombosis: evidence for a role of inflammation in thrombosis. Br J Haematol (2002) 1.22
Risk of Arterial Thrombosis in Relation to Oral Contraceptives (RATIO) study: oral contraceptives and the risk of ischemic stroke. Stroke (2002) 1.21
A C1173T dimorphism in the VKORC1 gene determines coumarin sensitivity and bleeding risk. PLoS Med (2005) 1.20
ADAMTS13 and von Willebrand factor and the risk of myocardial infarction in men. Blood (2006) 1.18
Genetic variation associated with plasma von Willebrand factor levels and the risk of incident venous thrombosis. Blood (2010) 1.17
Risk of failure of transvenous implantable cardioverter-defibrillator leads. Circ Arrhythm Electrophysiol (2009) 1.17
Venous thrombosis risk associated with plasma hypofibrinolysis is explained by elevated plasma levels of TAFI and PAI-1. Blood (2010) 1.16
Risk factors for venous thrombosis - current understanding from an epidemiological point of view. Br J Haematol (2010) 1.16
Arterial cardiovascular risk factors and venous thrombosis: results from a population-based, prospective study (the HUNT 2). Haematologica (2009) 1.15
Risk of venous thromboembolism in lung cancer. Curr Opin Pulm Med (2007) 1.14
Activated protein C resistance determined with a thrombin generation-based test predicts for venous thrombosis in men and women. Br J Haematol (2003) 1.14
Infectious complications of central venous catheters increase the risk of catheter-related thrombosis in hematology patients: a prospective study. J Clin Oncol (2005) 1.12
Quantification of bias in direct effects estimates due to different types of measurement error in the mediator. Epidemiology (2012) 1.11
Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study. Arterioscler Thromb Vasc Biol (2011) 1.10
Reduced plasma fibrinolytic potential is a risk factor for venous thrombosis. Blood (2004) 1.10
Loading and maintenance dose algorithms for phenprocoumon and acenocoumarol using patient characteristics and pharmacogenetic data. Eur Heart J (2011) 1.07
Prevalence of colonisation with group B Streptococci in pregnant women of a multi-ethnic population in The Netherlands. Eur J Obstet Gynecol Reprod Biol (2005) 1.07
Detection and functional analysis of CD8+ T cells specific for PRAME: a target for T-cell therapy. Clin Cancer Res (2006) 1.06
No association between the common MTHFR 677C->T polymorphism and venous thrombosis: results from the MEGA study. Arch Intern Med (2007) 1.06
Protein Z and protein Z-dependent protease inhibitor. Determinants of levels and risk of venous thrombosis. Thromb Haemost (2005) 1.06
Heart rate variability and first cardiovascular event in populations without known cardiovascular disease: meta-analysis and dose-response meta-regression. Europace (2013) 1.05
The relationship between exercise and risk of venous thrombosis in elderly people. J Am Geriatr Soc (2008) 1.05
Cediranib monotherapy in patients with advanced renal cell carcinoma: results of a randomised phase II study. Eur J Cancer (2012) 1.04
Minor injuries as a risk factor for venous thrombosis. Arch Intern Med (2008) 1.04
The value of family history as a risk indicator for venous thrombosis. Arch Intern Med (2009) 1.04
SNPs in microRNA binding sites in 3'-UTRs of RAAS genes influence arterial blood pressure and risk of myocardial infarction. Am J Hypertens (2011) 1.03
Thirty years of hemophilia treatment in the Netherlands, 1972-2001. Blood (2004) 1.03
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med (2012) 1.03
Current vaccination strategies for prostate cancer. Eur Urol (2011) 1.01